Novo Nordisk just pulled off something nobody saw coming

Novo Nordisk just got a big win from the FDA, and it could change the weight-loss medicine industry again. A new launch could reshape obesity treatment Christo/Corbis via Getty Images Novo has a new weapon in its obesity portfolio with the once-daily Wegovy tablet, which is the first oral GLP-1 medication approved in the U.S. […]

Queer Eye’s Jonathan Van Ness Shares Ab Selfie After GLP-1 Weight Loss

Jonathan Van Ness is showing off his figure after openly discussing his GLP-1 weight loss. “Sorry not sorry for leading with abs before Antoni & my mom,” the Queer Eye star, 38, wrote via Instagram on Sunday, December 28, alongside a carousel of photos. The first pic featured the hair stylist shirtless in the gym, […]

Why Eli Lilly Is the Unexpected Must-Buy Dividend Powerhouse to Own in 2026

Quick Read Eli Lilly (LLY) achieved 54% year-over-year revenue growth to $17.6B in Q3. Tirzepatide is projected as the top-selling drug by 2030. Lilly raised its quarterly dividend 15% to $1.73 per share. The company has increased dividends at a 16% annual rate over the past five years. If you’re focused on picking the right […]

GLP-1R Agonism Directly Improves the Pumping Capacity of Murine Collecting Lymphatic Vessels

Background: Glucagon-like peptide-1 receptor (GLP-1R) agonists have recently been suggested as effective therapies to treat or reduce the risk of developing secondary lymphedema in patients with obesity; however, it is unknown whether the observed improvement in lymphatic function is solely due to weight loss-associated systemic benefits or in synergy with a lymphatic-specific effect of these […]

Should You Invest in Ozempic Maker Novo Nordisk in 2026? – The Motley Fool

Should You Invest in Ozempic Maker Novo Nordisk in 2026?  The Motley Fool Weight-loss pill approval set to accelerate food industry product overhauls  Reuters Best Semaglutide Options for 2026: New Oral Wegovy Pill Approved by FDA as Patients Compare Injectable and Compounded Access Pathways  Yahoo Finance Weight-Loss Drugs Are Changing. Here’s What to Know  Bloomberg.com The FDA just approved […]